| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.0096 | 0.8 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | 0.043 | 0.8 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.0092 | 0.8 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | 0.0092 | 0.8 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.009 | 0.8 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | -0.047 | 0.8 |